Geron to Present at the Needham Healthcare Conference
05 avr. 2016 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., April 05, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron Announces Presentations at American Association of Cancer Research Annual Meeting
17 mars 2016 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., March 17, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that two abstracts describing non-clinical data on imetelstat have been accepted for...
Geron Corporation Reports Fourth Quarter and Annual 2015 Financial Results
25 févr. 2016 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2015 and recent events. ...
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2015 Financial Results
17 févr. 2016 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2015, on Thursday,...
Geron to Present at the RBC Capital Markets Healthcare Conference
10 févr. 2016 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Feb. 10, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes
14 janv. 2016 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the dosing of the first patient in a Phase 2/3 clinical trial to evaluate imetelstat in...
Geron Announces December Conference Presentation Webcasts
30 nov. 2015 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron to Present At the Stifel Healthcare Conference
10 nov. 2015 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Corporation Reports Third Quarter 2015 Financial Results
05 nov. 2015 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the third quarter ended September 30, 2015. For the third quarter of...
Geron Announces Presentations at American Society of Hematology Annual Meeting
05 nov. 2015 09h03 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that three abstracts describing clinical and non-clinical data on imetelstat have been...